Arrowhead Pharmaceuticals
ARWR
#2150
Rank
A$12.71 B
Marketcap
A$90.82
Share price
0.35%
Change (1 day)
366.34%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): A$0.63

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A$0.51. an increase over its 2024 EPS that were of A-$7.22.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025A-$0.01443-99.8%
2024A-$7.22161.39%
2023A-$2.7617.36%
2022A-$2.3519.85%
2021A-$1.9661.9%
2020A-$1.21-216.67%
2019A$1.04-210.77%
2018A-$0.9438.3%
2017A-$0.68-64.93%
2016A-$1.93-16.25%
2015A-$2.3128%
2014A-$1.80-3.85%
2013A-$1.88-31.58%
2012A-$2.74331.82%
2011A-$0.64-51.11%
2010A-$1.30-79.07%
2009A-$6.21-37.68%
2008A-$9.96-16.87%
2007A-$11.9838.33%
2006A-$8.66122.22%
2005A-$3.9042.11%
2004A-$2.74533.33%
2003A-$0.43-99.08%
2002A-$46.8625%
2001A-$37.4933.33%
2000A-$28.12-120%
1999A$140.59-400%
1998A-$46.86-81.48%
1997A-$253.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$16.08 3,082.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
A-$10.49-2,177.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$9.09 1,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$2.60 414.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
A-$4.16-922.86%๐Ÿ‡บ๐Ÿ‡ธ USA